Beta-2 microglobulin and neopterin as markers of disease activity in multiple sclerosis

Neurological Sciences

Volumn 24, Issue SUPPL. 5, 2003, Pages

  Bagnato, F ^a   Durastanti, V ^a   Finamore, L ^a   Volante, G ^a   Millefiorini, E ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Beta 2 microglobulin; Biological markers; Magnetic resonance imaging; Multiple sclerosis; Neopterin

Indexed keywords

BETA 2 MICROGLOBULIN; BETA INTERFERON; BETA1A INTERFERON; BIOCHEMICAL MARKER; NEOPTERIN; NEUTRALIZING ANTIBODY;

ARTICLE; AUTOIMMUNE DISEASE; BODY FLUID; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL EXAMINATION; CORRELATION ANALYSIS; DISEASE ACTIVITY; DISEASE COURSE; DISEASE MARKER; HUMAN; MULTIPLE SCLEROSIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT MONITORING; PHARMACODYNAMICS; PROTEIN BLOOD LEVEL; PROTEIN STABILITY; RELAPSE; TH1 CELL; URINARY EXCRETION;

BETA 2-MICROGLOBULIN; BIOLOGICAL MARKERS; HUMANS; MULTIPLE SCLEROSIS; NEOPTERIN;

EID: 0345602735     PISSN: 15901874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10072-003-0180-5     Document Type: Article

References (15)

1. Prat E, Martin R (2002) The immunopathogenesis of multiple sclerosis. J Rehabil Res Dev 39:187-199
2. McFarland HF (2000) The emerging role of MRI in multiple sclerosis and the new diagnostic criteria. Mult Scler 8:71-72
3. Barkhof F (1999) MRI in multiple sclerosis: correlation with expanded disability status scale (EDSS). Mult Scler 5:283-286
4. Sorensen PS (1999) Biological markers in body fluids for activity and progression in multiple sclerosis. Mult Scler 5:287-290
5. Rudick RA, Simonian NA, Alam JA et al (1998) Incidence and significance of neutralizing antibodies to interferon beta-1a in multiple sclerosis. Neurology 50:1226-1272
6. Bagnato F, Pozzilli C, Scagnolari C et al (2002) A one-year study on the pharmacodynamic profile of interferon-beta 1a in MS. Neurology 58:1409-1411
7. Messner RP (1984) β2-Microglobulin: an old molecule assumes a new look. J Lab Clin Med 104:141-145
8. Bjerrum OW, Bach FW, Zeeberg I (1988) Increased level of cerebrospinal fluid β2-microglobulin is related to neurological impairment in multiple sclerosis. Acta Neurol Scand 78:72-75
9. Carrieri PB, Indaco A, Maiorini A (1992) Cerebrospinal fluid beta-2 microglobulin in multiple sclerosis and AIDS dementia complex. Neurol Res 14:282-283
10. Ott M, Lothar D, Engelhardt W, Fischer PA (1993) Interleukin-2, soluble interleukin-2-receptor, neopterin, L-tryptophan and β2-microglobulin levels in CSF and serum of patients with relapsing-remitting or chronic-progressive multiple sclerosis. J Neurol 241:108-114
11. Hamerlinck FFV (1999) Neopterin: a review. Exp, Dermatol 8:167-176
12. Shaw CE, Dunbar PR, Macaulay HA, Neale TJ (1995) Measurement of immune markers in the serum and cerebrospinal fluid of multiple sclerosis patients during clinical remission. J Neurol 242:53-58
13. Giovannoni G, Lai M, Kidd D et al (1997) Daily urinary neopterin excretion as an immunological marker of disease activity in multiple sclerosis. Brain 120:1-13
14. Rudzite V, Berzinsh J, Grivane I et al (1996) Serum tryptophan, kynurenine, and neopterin in patients with Guillain-Barré-syndrome (GBS) and multiple sclerosis (MS). Adv Exp Med Biol 398:183-187
15. Giovannoni G, Miller DH, Losseff NA et al (2001) Serum inflammatory markers and clinical/MRI markers of disease progression in multiple sclerosis. J Neurol 248:487-495